The company had posted a net profit of Rs 44.8 crore during the same period of previous fiscal, Sanofi India said in a filing to the BSE.
Net sales of the company rose to Rs 481.1 crore for the fourth quarter, as compared to Rs 400.7 crore during the same period of previous fiscal.
The company follows a January-December financial year.
For the year ended December 31, 2013, the company posted a net profit of Rs 265.2 crore, compared to Rs 176.7 crore in 2012.
The company's board, which met today, has recommended final dividend of Rs 35 per equity share of Rs 10 for the year ended December 31, 2013.
Sanofi India shares today closed at Rs 2640.20 apiece on the BSE, down 3.61 per cent from previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
